Diabetes Care:代谢综合征可发生大脑白质改变

2012-12-04 Diabetes Care Diabetes Care

  来自日本的一项研究表明,代谢综合征患者可发生脑白质的微结构变化。其中,各向异性分数(FA)值可能是评价??代谢综合征患者白质改变的有价值指标。研究在2012年11月19日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在评价代谢综合征患者白质变化的区域表型。此外,研究还探讨了白质的改变是否与体质指数(BMI)相关。   研究共纳入7例患有代谢综合征的中年

  来自日本的一项研究表明,代谢综合征患者可发生脑白质的微结构变化。其中,各向异性分数(FA)值可能是评价​​代谢综合征患者白质改变的有价值指标。研究在2012年11月19日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  该研究旨在评价代谢综合征患者白质变化的区域表型。此外,研究还探讨了白质的改变是否与体质指数(BMI)相关。

  研究共纳入7例患有代谢综合征的中年男性受试者及7例无代谢综合征的中年男性受试者,应用3T磁共振成像设备对受试者进行弥散张量成像。研究采用基于纤维束示踪的空间统计分析(Tract-Based Spatial Statistics,TBSS)方法(全脑分析),分析了各向异性分数(FA)值。其后,采用示踪特异性分析(脑区域分析),测量评价了所有受试者右下额叶-枕叶束(IFOF)的平均FA值。使用Pearson相关系数,评估右下额叶-枕叶束平均FA值和BMI之间的关系。

  全脑分析结果表明,患有代谢综合征受试者的较对照组表现为显著降低的FA值,出现部位包括右侧外囊(部分的右IFOF),整个胼胝体和右前侧额叶的部分深部白质。脑区域分析结果表明,代谢综合征受试者右侧IFOF的平均FA值为0.44±0.05,对照组为0.41±0.03。BMI值和FA值之间存在显著的负相关关系(r = -0.56,P <0.04)。


White Matter Alteration in Metabolic Syndrome

OBJECTIVE 

We explored the regional pattern of white matter alteration in subjects with metabolic syndrome. We also investigated whether white matter alteration was correlated with BMI.

RESEARCH DESIGN AND METHODS 

Seven middle-aged men with metabolic syndrome and seven without metabolic syndrome underwent diffusion tensor imaging with a 3T magnetic resonance imaging imager. We analyzed the fractional anisotropy (FA) values by using a tract-based spatial statistics technique (whole-brain analysis). We subsequently focused on measuring the mean FA values of the right inferior fronto-occipital fasciculus (IFOF) of all subjects by tract-specific analysis (regional brain analysis). We used Pearson correlation coefficient to evaluate the relationship between BMI and mean FA values of the right IFOF.

RESULTS 

In the whole-brain analysis, subjects with metabolic syndrome had significantly lower FA values than control subjects in part of the right external capsule (part of the right IFOF), the entire corpus callosum, and part of the deep white matter of the right frontal lobe. In the regional brain analysis, the mean FA value of the right IFOF was 0.41 ± 0.03 for subjects with metabolic syndrome and 0.44 ± 0.05 for control subjects. A significant negative correlation was observed between BMI and FA values in the right IFOF (r = 0.56, P < 0.04).

CONCLUSIONS 

Our results show that microstructural white matter changes occur in patients with metabolic syndrome. FA values may be useful indices of white matter alterations in patients with metabolic syndrome.


    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901026, encodeId=92591901026d0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Sep 30 13:45:00 CST 2013, time=2013-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636594, encodeId=c6ed163659441, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 03 14:45:00 CST 2013, time=2013-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759217, encodeId=16711e5921791, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 20 20:45:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765490, encodeId=74481e6549006, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jan 16 18:45:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430355, encodeId=ba6514303556e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Dec 06 02:45:00 CST 2012, time=2012-12-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901026, encodeId=92591901026d0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Sep 30 13:45:00 CST 2013, time=2013-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636594, encodeId=c6ed163659441, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 03 14:45:00 CST 2013, time=2013-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759217, encodeId=16711e5921791, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 20 20:45:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765490, encodeId=74481e6549006, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jan 16 18:45:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430355, encodeId=ba6514303556e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Dec 06 02:45:00 CST 2012, time=2012-12-06, status=1, ipAttribution=)]
    2013-04-03 智智灵药
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901026, encodeId=92591901026d0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Sep 30 13:45:00 CST 2013, time=2013-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636594, encodeId=c6ed163659441, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 03 14:45:00 CST 2013, time=2013-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759217, encodeId=16711e5921791, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 20 20:45:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765490, encodeId=74481e6549006, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jan 16 18:45:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430355, encodeId=ba6514303556e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Dec 06 02:45:00 CST 2012, time=2012-12-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901026, encodeId=92591901026d0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Sep 30 13:45:00 CST 2013, time=2013-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636594, encodeId=c6ed163659441, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 03 14:45:00 CST 2013, time=2013-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759217, encodeId=16711e5921791, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 20 20:45:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765490, encodeId=74481e6549006, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jan 16 18:45:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430355, encodeId=ba6514303556e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Dec 06 02:45:00 CST 2012, time=2012-12-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1901026, encodeId=92591901026d0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Sep 30 13:45:00 CST 2013, time=2013-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636594, encodeId=c6ed163659441, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 03 14:45:00 CST 2013, time=2013-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759217, encodeId=16711e5921791, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 20 20:45:00 CST 2013, time=2013-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765490, encodeId=74481e6549006, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jan 16 18:45:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430355, encodeId=ba6514303556e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Dec 06 02:45:00 CST 2012, time=2012-12-06, status=1, ipAttribution=)]

相关资讯

中国脑卒中发病者约30死亡 防控形势不容乐观

  “我国每年新发脑卒中患者约有200万例,且还在以每年近9%的速率迅速增长,发病者约30%死亡。”29日,中华预防医学会会长、中国工程院院士王陇德在“世界卒中日”宣传周系列活动上如上表示。今年的活动主题是“关注脑卒中,立即行动”。   当前,我国脑卒中防控形势严峻。随着慢性病发病年龄的提前、农村患病人数的快速增加和人口老龄化趋势加速。世界银行2011年7月在《创建健康和谐生活,遏制中国慢病流行

Diabetes Care:脂肪肝和胰岛素抵抗与冠脉钙化相关

  非酒精性脂肪肝(NAFLD)常与胰岛素抵抗(IR)并存,但二者是否与动脉粥样硬化独立相关并不明确。近期一项研究发现,脂肪肝和胰岛素抵抗均与冠状动脉钙化独立相关。研究于7月24日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究涉及10153例韩国人群,受试者接受超声检查脂肪肝和心脏CT评估冠状动脉钙化(CAC)评分。IR定义为稳态模型胰岛素抵抗指数(HOMA-IR)≥第7

Pediatrics:MetS与青少年的认知能力和脑功能损伤有关

    纽约大学医学院的研究人员开展的一项新研究中首次显示代谢综合征(MetS)与青少年的认知能力和脑功能损伤有关,并呼吁儿科医生在儿童肥胖的早期治疗中将这一点也考虑在内。     这项研究受美国国立卫生研究院,资助编号为DK083537,并受到国家研究资源中心编号为1ULIRR029892的部分资助,研究结果已在线发表于9月3日的儿科

ACR:代谢综合征可增加原发性抗磷脂综合征患者发生动脉事件的风险

代谢综合征是原发性抗磷脂综合征病人发生动脉事件的一个独立危险因素在全世界范围内,代谢综合征(MetS)是一个主要的公共卫生问题。据报道,在原发性抗磷脂综合征(APS)病人中,MetS的发病率也很高。由于MetS和APS在引起内皮细胞功能障碍和增加血栓形成上有相似性,使得2种疾病共存的病人的表现可能不同也可能加重。目前此类文献报道仅有一例且APS病人的MetS发病率高。针对这种情况来自巴西圣保罗大学

抗疟药氯喹有望用于治疗代谢综合征

抗疟疾/免疫调节药物氯喹可能将增加一项新的用途——治疗代谢综合征患者。 之前华盛顿大学的一项动物研究显示,每日给予氯喹或羟基氯喹治疗可减轻胰岛素抵抗并改善血脂代谢,这很可能是通过激活共济失调毛细血管扩张症基因突变(ATM)实现的(Cell Metab. 2006;4:377-89)。基于动物研究的结果,进行了一系列的大型前瞻性临床试验,评估每日氯喹治疗对于血脂异常和胰岛素抵抗的疗效。 新加坡国

BMJ Open:快走和慢跑能减少心脏病和糖尿病风险

      有许多研究指出,每天以适当的速度步行30分钟这种规律的运动,就有可能改善健康。但最新研究显示,快走、慢跑、以及其他更剧烈的运动,能减少你的心脏病和糖尿病风险;重点是运动的强度,而不是持续的时间。研究结果10月8日刊载在BMJ Open上。     具体而言,每周快走和慢跑2-4小时,可能减少50%的代谢综合征风险;每天以轻松的步伐走大约1个小时,罹患代